🇺🇸 FDA
Pipeline program

ACETYLSALICYLIC ACID, PRASUGREL

RM21

Approved small_molecule active

Quick answer

ACETYLSALICYLIC ACID, PRASUGREL for St-Elevated Myocardial Infartion is a Approved program (small_molecule) at Cardiol Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiol Therapeutics
Indication
St-Elevated Myocardial Infartion
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials